Latest Breaking News On - Marketing authorization holder - Page 7 : comparemela.com

Pfizer Inc : Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB 1 5-adapted COVID-19 Vaccine in the European Union

Pfizer Inc : Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB 1 5-adapted COVID-19 Vaccine in the European Union
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAlbert bourlaFosun pharmaUgur sahinEuropean commissionEuropean unionDrug administrationCenters for diseaseEuropean medicines agencyWorld health organizationCommittee for medicinal products human useExchange commissionRoche groupEuropean commission for the omicronPfizer inc

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB 1 5-adapted COVID-19 Vaccine in the European Union

The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation based on pre-clinical data.

United statesUnited kingdomUgur sahinFosun pharmaAlbert bourlaRoche groupPfizer incEuropean commission for the omicronEuropean commissionEuropean medicines agencyCenters for diseaseDrug administrationEuropean unionCommittee for medicinal products human useExchange commissionWorld health organization

EU CHMP Backs Pfizer-BioNTech s Omicron-Adapted Vaccine

EU CHMP Backs Pfizer-BioNTech s Omicron-Adapted Vaccine
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomUgur sahinAlbert bourlaDrug administrationCenters for diseaseEuropean unionEuropean medicines agencyPfizer incEuropean commissionCommittee for medicinal products human useMedicinal productsHuman useChief executive officerMarketing authorization holderEmergency use authorization

Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel

Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalUnited kingdomNew jerseyUnited statesNova scotiaUnited arab emiratesWest bankState of israelGreat britainSteven ketchumMark marmurPatrick holtIsraeli ministry of healthPalestinian authorityJordan zwick amarin corporationExchange commission

Amarin (AMRN) And Neopharm Enter Exclusive Commercialization Agreement for VAZKEPA in Israel

Amarin (AMRN) And Neopharm Enter Exclusive Commercialization Agreement for VAZKEPA in Israel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalUnited arab emiratesWest bankNew jerseyUnited statesUnited kingdomState of israelGreat britainPatrick holtSteven ketchumPharmaceuticals divisionJordan zwick amarin corporationExchange commissionHealth information divisionResearch developmentIsraeli ministry of health